tiprankstipranks
Trending News
More News >
Aarti Drugs Limited (IN:AARTIDRUGS)
:AARTIDRUGS
India Market

Aarti Drugs Limited (AARTIDRUGS) Ratios

Compare
3 Followers

Aarti Drugs Limited Ratios

IN:AARTIDRUGS's free cash flow for Q1 2026 was ₹0.37. For the 2026 fiscal year, IN:AARTIDRUGS's free cash flow was decreased by ₹ and operating cash flow was ₹0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
0.00 1.66 1.66 1.60 1.48
Quick Ratio
0.00 1.05 1.05 1.05 0.92
Cash Ratio
0.00 <0.01 <0.01 <0.01 0.02
Solvency Ratio
-0.18 0.19 0.19 0.18 0.22
Operating Cash Flow Ratio
0.00 0.45 0.45 0.14 0.07
Short-Term Operating Cash Flow Coverage
0.00 1.25 1.25 0.33 0.17
Net Current Asset Value
₹ 13.69B₹ 1.70B₹ 1.70B₹ 2.64B₹ 2.22B
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.23 0.23 0.25 0.25
Debt-to-Equity Ratio
0.00 0.44 0.44 0.51 0.52
Debt-to-Capital Ratio
0.00 0.31 0.31 0.34 0.34
Long-Term Debt-to-Capital Ratio
0.00 0.18 0.18 0.15 0.12
Financial Leverage Ratio
0.00 1.90 1.90 2.03 2.13
Debt Service Coverage Ratio
7.86 0.79 0.79 0.58 0.66
Interest Coverage Ratio
10.33 7.09 7.33 7.71 13.90
Debt to Market Cap
0.00 0.13 0.13 0.19 0.14
Interest Debt Per Share
3.91 65.20 65.20 69.35 60.86
Net Debt to EBITDA
0.00 1.74 1.74 1.93 1.52
Profitability Margins
Gross Profit Margin
34.11%33.65%14.00%30.47%20.24%
EBIT Margin
10.51%10.64%10.72%9.48%11.68%
EBITDA Margin
12.83%12.67%12.77%11.47%13.82%
Operating Profit Margin
15.24%10.62%11.07%9.45%11.59%
Pretax Profit Margin
9.04%9.31%9.39%8.25%10.85%
Net Profit Margin
7.80%6.78%6.83%6.12%8.24%
Continuous Operations Profit Margin
7.79%6.79%6.84%6.12%8.24%
Net Income Per EBT
86.26%72.78%72.78%74.19%75.95%
EBT Per EBIT
59.31%87.67%84.81%87.31%93.61%
Return on Assets (ROA)
0.00%7.05%7.05%6.87%9.29%
Return on Equity (ROE)
14.27%13.38%13.38%13.95%19.78%
Return on Capital Employed (ROCE)
0.00%16.41%16.97%17.25%22.75%
Return on Invested Capital (ROIC)
0.00%10.17%10.51%10.07%13.11%
Return on Tangible Assets
0.00%7.16%7.16%6.87%9.29%
Earnings Yield
3.97%4.06%4.06%5.32%5.16%
Efficiency Ratios
Receivables Turnover
0.00 3.59 3.56 3.14 3.32
Payables Turnover
0.00 3.73 4.80 3.83 4.23
Inventory Turnover
0.00 3.45 4.44 3.66 3.77
Fixed Asset Turnover
0.00 2.40 2.38 3.07 3.25
Asset Turnover
0.00 1.04 1.03 1.12 1.13
Working Capital Turnover Ratio
9.66 4.73 4.63 5.36 5.44
Cash Conversion Cycle
0.00 109.60 108.64 120.81 120.52
Days of Sales Outstanding
0.00 101.70 102.50 116.22 109.99
Days of Inventory Outstanding
0.00 105.71 82.19 99.79 96.72
Days of Payables Outstanding
0.00 97.82 76.06 95.19 86.19
Operating Cycle
0.00 207.41 184.70 216.01 206.70
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 38.86 38.86 14.49 7.52
Free Cash Flow Per Share
0.00 14.36 14.36 -3.29 -8.89
CapEx Per Share
0.00 24.51 24.51 17.78 16.41
Free Cash Flow to Operating Cash Flow
0.00 0.37 0.37 -0.23 -1.18
Dividend Paid and CapEx Coverage Ratio
0.00 1.52 1.52 0.77 0.43
Capital Expenditure Coverage Ratio
0.00 1.59 1.59 0.81 0.46
Operating Cash Flow Coverage Ratio
0.00 0.64 0.64 0.22 0.13
Operating Cash Flow to Sales Ratio
0.00 0.14 0.14 0.05 0.03
Free Cash Flow Yield
0.00%3.14%3.14%-0.97%-2.07%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
25.16 24.64 24.64 18.81 19.38
Price-to-Sales (P/S) Ratio
1.96 1.67 1.68 1.15 1.60
Price-to-Book (P/B) Ratio
3.47 3.30 3.30 2.62 3.83
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 31.86 31.86 -102.64 -48.26
Price-to-Operating Cash Flow Ratio
0.00 11.77 11.77 23.31 57.06
Price-to-Earnings Growth (PEG) Ratio
2.02 7.38 7.38 -1.00 -0.73
Price-to-Fair Value
3.47 3.30 3.30 2.62 3.83
Enterprise Value Multiple
15.28 14.92 14.92 11.96 13.07
Enterprise Value
47.51B 47.82B 47.82B 37.28B 44.95B
EV to EBITDA
15.28 14.92 14.92 11.96 13.07
EV to Sales
1.96 1.89 1.91 1.37 1.81
EV to Free Cash Flow
0.00 36.07 36.07 -122.33 -54.59
EV to Operating Cash Flow
0.00 13.32 13.32 27.78 64.55
Tangible Book Value Per Share
150.03 134.81 134.81 128.71 111.90
Shareholders’ Equity Per Share
150.03 138.76 138.76 128.77 111.92
Tax and Other Ratios
Effective Tax Rate
0.14 0.27 0.27 0.26 0.24
Revenue Per Share
265.39 273.77 271.64 293.31 268.75
Net Income Per Share
20.69 18.56 18.56 17.96 22.14
Tax Burden
0.86 0.73 0.73 0.74 0.76
Interest Burden
0.86 0.88 0.88 0.87 0.93
Research & Development to Revenue
<0.01 <0.01 0.00 <0.01 <0.01
SG&A to Revenue
0.01 <0.01 <0.01 <0.01 <0.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 2.09 2.09 0.60 0.26
Currency in INR